1. Lipshultz, SE and Sleeper, LA and Towbin, JA and Lowe, AM and Orav, EJ and Cox, GF and (2003) The incidence of pediatric cardiomyopathy in two regions of the United States N Engl J Med, 348, pp. 1647 - 55.
2. Aretz, HT and Billingham, ME and Edwards, WD and Factor, SM and Fallon, JT and Fenoglio, JJ, Jr and (1987) Myocarditis. A histopathologic definition and classification Am J Cardiovasc Pathol, 1, pp. 3 - 14.
3. Kuhl, U and Noutsias, M and Seeberg, B and Schultheiss, HP. (1996) Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy Heart, 75, pp. 295 - 300.
4. Wojnicz, R and Nowalany-Kozielska, E and Wojciechowska, C and Glanowska, G and Wilczewski, P and Niklewski, T and (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy. Two-year follow-up result Circulation, 104, pp. 39 - 45.
5. Caforio, AL and Bonifacio, E and Stewart, JT and Neglia, D and Parodi, O and Bottazzo, GF and (1990) Novel organ-specific circulating autoantibodies in dilated cardiomyopathy J Am Coll Cardiol, 15, pp. 1527 - 34.